Australian Court Upholds Pfizer's Lipitor Patent

Law360, New York (May 28, 2008, 12:00 AM EDT) -- An Australian court has dismissed Ranbaxy Pharmaceuticals Inc.'s appeal of an order that prevented the drugmaker from launching a generic version of Pfizer Inc.'s anti-cholesterol drug Lipitor.

On Wednesday, the Federal Court of Australia in Victoria dismissed Ranbaxy's appeal of a previous court order that enjoined the generics company from infringing a Pfizer patent for Lipitor. The court also dismissed Pfizer's appeal of a court order that revoked another underlying patent for Lipitor.

The court found that Ranbaxy's generic drug would infringe Pfizer's basic Lipitor patent...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.